December 03, 2025
An investor is asking a New York federal court to approve a $10 million deal to end a nearly 5-year-old class action accusing cannabis company Cronos Group Inc. and its executives of artificially inflating company revenue by improperly recording "round-trip" transitions as sales.
December 04, 2024
A New York federal judge has given a group of investors another chance to pursue claims that Cronos Group Inc. misled backers about its financial benchmarks, saying allegations stemming from a U.S. Securities and Exchange Commission settlement could be enough for the claims to survive.
January 03, 2024
Cannabis company Cronos Group Inc. has urged a New York federal court not to resurrect a dismissed investor-led securities fraud lawsuit, saying the plaintiff had numerous chances to amend his suit to include alleged misconduct by one of its executives but repeatedly chose not to.
December 05, 2023
An investor who alleged cannabis company Cronos Group Inc. violated "black-and-white accounting standards" to artificially boost quarterly revenue by 40% is asking to amend a consolidated lawsuit's claims post-dismissal, arguing that a New York federal judge's November decision to toss the case with prejudice ran afoul of Second Circuit precedent.
November 20, 2023
A New York federal judge has thrown out a consolidated investor suit alleging Canadian cannabis company Cronos Group Inc. misled investors about its revenue, saying the consolidated complaint fails to indicate that the company's officers were making deliberate misstatements.
April 23, 2021
Cronos Group, a Canadian cannabis company at the center of a consolidated group of stock-drop shareholder suits, told a New York federal judge on Thursday that the investors had failed to claim the company acted fraudulently when it revised its earnings reports.